Pharmalot
Contributor since: 2010
Latest Articles
Google Forfeits $500M Over Online Pharmacy Ads
Bayer and J&J 'Muddied The Waters' With Xarelto
J&J to Settle Risperdal Criminal Charge, While 40 States Plan Lawsuits
Roche Suggests a Compromise Over Avastin
Feds Will Not Ban Forest CEO From Health Programs
Doctor Who Is a Provenge Fan Says Reimbursement Is a Risk
Genzyme Angers Patients Over Fabrazyme Supplies
For Pfizer, Is Taking Lipitor OTC a Good Idea?
Biotechs: Revenues Rise, But So Do Cutbacks in R&D
DaVita Wasted Drugs to Make Big Money Off Medicare
AstraZeneca's Bloodthinner Pricing Questioned
Express Scripts to Buy Medco Health Solutions
Johnson & Johnson Special Committee: No Wrongdoing
Feds Probe Cephalon for Off-Label Treanda Promotion: Implications for Teva Are Unclear
Pfizer to Shed Animal Health and Nutrition Units
Sanofi Ends Heart Med Trial Over Cardiovascular Events
Pfizer: The Gutted R&D Machine
Glaxo Overhauls Pay for Sales Reps
Smoked: Pfizer's Chantix and Concerns About Heart Problems
Studies on Medtronic's Infuse Repudiated by Medical Journal
Biotech Deals Fail to Yield Results
The Bristol and Pfizer Blood Thinner: 'A Major Win'
FDA Has a New 'Global Strategy' to Monitor Imports
Lilly Wins a Round in Its Fight With Amylin
Pfizer to Cut Another $1 Billion in Expenses
A 'Game Changing' Ruling for Pharma Whistleblowers
Abbott Cholesterol Pill Fails to Protect the Heart
FDA Oversight of Johnson & Johnson Is 'Troubling'
FDA to Limit Access to Glaxo's Avandia
ISMP Study Shows Pfizer Failed to Report Chantix Side Effects to FDA
Merck and Roche to Collaborate on Hepatitis C Meds
Will FDA Limit Use of an Abbott Cholesterol Pill?